retatrutide phase 3 trial 🚨The first trial, TRIUMPH-4, top-line data announced today 🚨 Efficacy and safety of retatrutide,

Sjstrm, R.J

Many plans require prior authorization, step therapy, or higher copays for weight management use, pushing patients toward out-of-pocket payment or compounded alternatives, which may not be covered but often cost less upfront

The same 8mg target dose was assigned to two groups: one starting at 2mg (slow), one starting at 4mg (fast)

P5 treatment increased phospho-AMPK levels (a direct measure of AMPK activation) in the outer root sheath and dermal papilla cells of follicles, elevated the Ki-67 proliferation marker in matrix cells of cultured follicle bulbs (Ki-67 is a protein found only in actively dividing cells), and raised overall hair cycle scores